股溜產業平台

高端疫苗

6547上櫃
46.90−0.65−1.37%收盤・資料日 2026-11-06
股期

營收與獲利單位:億元;資料到 2026 Q2

2026 Q21.15 億元0.94 億元0.21 億元0.22 億元

營收與獲利(億元;單季)

21Q422Q222Q423Q223Q424Q224Q425Q225Q426Q2

損益表單位:億元(每股盈餘:元);單季,最新在左

科目2026 Q22026 Q12025 Q42025 Q32025 Q22025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q3
營業收入淨額1.151.061.472.061.451.151.292.431.750.591.712.180.000.000.240.020.133.2720.3012.47
營業成本0.210.270.411.240.440.400.571.040.350.140.521.070.000.004.440.000.171.176.003.73
營業毛利0.940.791.060.821.010.750.721.391.400.451.191.110.000.00−4.200.02−0.052.1014.308.74
營業費用0.721.112.491.101.631.081.171.311.431.526.651.983.562.252.753.743.133.623.822.21
推銷費用0.340.380.570.520.480.430.570.660.680.340.770.530.150.130.330.150.130.110.020.02
管理費用0.260.350.260.240.250.170.290.240.200.220.220.210.190.250.250.270.270.320.430.46
研究發展費用0.130.381.660.340.910.480.310.410.550.955.671.253.221.872.173.322.733.183.361.73
營業利益0.21−0.32−1.43−0.28−0.62−0.33−0.450.09−0.03−1.07−5.46−0.87−3.56−2.25−6.95−3.72−3.18−1.5210.496.53
營業外收入及支出0.010.040.050.05−0.380.120.23−0.070.160.33−0.360.350.430.12−0.220.620.100.110.170.27
財務成本0.060.030.020.020.020.020.020.020.050.090.090.090.090.090.090.090.060.020.020.02
稅前淨利0.22−0.28−1.38−0.23−1.00−0.21−0.220.020.14−0.73−5.82−0.52−3.14−2.12−7.17−3.09−3.08−1.4010.666.80
繼續營業單位損益0.22−0.28−1.38−0.23−1.00−0.21−0.220.020.14−0.73−5.82−0.52−3.14−2.12−7.17−3.09−3.08−1.4010.666.80
本期淨利(稅後)0.22−0.28−1.38−0.23−1.00−0.21−0.220.020.14−0.73−5.82−0.52−3.14−2.12−7.17−3.09−3.08−1.4010.666.80
歸屬母公司業主0.22−0.28−1.38−0.23−1.00−0.21−0.220.020.14−0.73−5.82−0.52−3.14−2.12−7.17−3.09−3.08−1.4010.666.80
本期綜合損益總額0.19−0.45−1.37−0.69−1.15−0.80−0.180.090.70−0.75−5.72−0.84−3.25−2.33−7.20−3.25−2.36−1.1210.666.80
綜合損益歸屬母公司業主0.19−0.45−1.37−0.69−1.15−0.80−0.180.090.70−0.75−5.72−0.84−3.25−2.33−7.20−3.25−2.36−1.1210.666.80
每股盈餘(元)0.07−0.09−0.42−0.07−0.30−0.06−0.060.000.04−0.22−1.77−0.16−0.96−0.65−2.21−0.95−1.44−0.665.023.20

財經資料來源:FinLab

股溜產業平台 產業資訊整理,不構成投資建議;數字以證交所、櫃買中心、集保公告為準。 資料日 2026-11-06